Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04419779 Org: User:
Start: 03/08/21 End: 01/31/26 Due: 01/31/27

Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01927562 Org: User:
Start: 07/13/13 End: 03/16/18 Due: 03/16/19

A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06256497 Org: User:
Start: 06/27/23 End: 12/01/28 Due: 12/01/29

Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)

Phase: N/A Priority: Normal
NCT ID: NCT02879383 Org: User:
Start: 03/01/17 End: 12/20/19 Due: 12/20/20

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Phase: N/A Priority: Normal
NCT ID: NCT06484114 Org: User:
Start: 09/01/24 End: 09/30/27 Due: 09/30/28

Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02413567 Org: User:
Start: 03/23/15 End: 09/18/19 Due: 09/18/20

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03653091 Org: User:
Start: 09/28/18 End: 08/10/20 Due: 08/10/21